• Ibalizumab, sold under the brand name Trogarzo, is a non-immunosuppressive humanised monoclonal antibody that binds CD4, the primary receptor for HIV,...
    9 KB (735 words) - 11:45, 12 December 2023
  • Adelaide: Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3 "Trogarzo- ibalizumab injection, solution". DailyMed. 8 April 2020. Retrieved 21 September 2020...
    13 KB (513 words) - 14:31, 4 May 2024
  • | Z Ia–Il | Im–In | Io–Ip | Iq–Iz ibacitabine (INN) ibafloxacin (INN) ibalizumab (INN) ibandronic acid (INN) ibazocine (INN) ibipinabant (USAN, INN) iboctadekin...
    5 KB (286 words) - 05:48, 8 August 2024
  • side effects are diarrhea, vomiting, runny nose and other cold symptoms. Ibalizumab (trade name: Trogarzo) is a new antiviral drug specifically for adults...
    27 KB (2,923 words) - 15:03, 4 April 2024
  • Thumbnail for Cabotegravir/rilpivirine
    T-20))◊ CCR5 (Maraviroc (MVC) Vicriviroc†, Cenicriviroc†, Leronlimab†) CD4 (Ibalizumab (IBA), Semzuvolimab§) gp120 (Fostemsavir (FTR)) Integrase inhibitors (Integrase...
    15 KB (1,230 words) - 02:38, 16 July 2024
  • Thumbnail for List of therapeutic monoclonal antibodies
    human IL-23 Y psoriasis Ianalumab mab human BAFF-R autoimmune hepatitis Ibalizumab Trogarzo mab humanized CD4 Y HIV infection Sintilimab human PD-1 squamous...
    136 KB (4,020 words) - 07:14, 15 August 2024
  • host cell by blocking one of several targets. Maraviroc, enfuvirtide and Ibalizumab are available agents in this class. Maraviroc works by targeting CCR5...
    133 KB (15,717 words) - 02:22, 8 August 2024
  • Durvalumab AstraZeneca UK unresectable Stage III non-small cell lung cancer Ibalizumab-uiyk Theratechnologies human immunodeficiency virus type 1 (HIV-1) infection...
    34 KB (180 words) - 22:09, 8 April 2024
  • approximate the two membranes. It is also referred to as a "fusion inhibitor." Ibalizumab, a monoclonal antibody that binds to domain 2 of CD4 and interferes with...
    9 KB (1,095 words) - 03:47, 25 December 2023
  • Vedolizumab Visilizumab Vobarilizumab TGN1412§ Immune activation: Dostarlimab Other: Ibalizumab Chimeric + humanized Otelixizumab Rozanolixizumab Sutimlimab...
    38 KB (4,304 words) - 10:14, 21 July 2024